TSRI stroke drug demonstrates safety in clinical trial

(Scripps Research Institute) 'These results lay the groundwork for the next steps toward FDA approval,' says John Griffin, PhD, professor at TSRI, whose team invented 3K3A-APC.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2C8k8LX